An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment

Antibody responses to SARS-CoV-2 in patients with COVID-19

Long, Q.-X., Liu, B.-Z., Deng, H.-J., Wu, G.-C., Deng, K., Chen, Y.-K., Liao, P., Qiu, J.-F., Lin, Y., Cai, X.-F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0897-1 · Cited by 2,876

Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period

Kissler, S. M., Tedijanto, C., Goldstein, E., Grad, Y. H., & Lipsitch, M. (2020) · Science · doi:10.1126/science.abb5793 · Cited by 2,611

Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019

Zhao, J., Yuan, Q., Wang, H., Liu, W., Liao, X., Su, Y., Wang, X., Yuan, J., Li, T., Li, J., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa344 · Cited by 2,607

Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients

Okba, N. M. A., Müller, M. A., Li, W., Wang, C., GeurtsvanKessel, C. H., Corman, V. M., Lamers, M. M., Sikkema, R. S., de Bruin, E., Chandler, F. D., et al. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2607.200841 · Cited by 1,614

Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe

Flaxman, S. R., Mishra, S., Gandy, A., Unwin, H. J. T., Mellan, T. A., Coupland, H., Whittaker, C., Zhu, H., Berah, T., Eaton, J. W., et al. (2020) · Spiral (Imperial College London) · doi:10.25561/77731 · Cited by 632

Evaluation of nine commercial SARS-CoV-2 immunoassaysPreprint

Lassaunière, R., Frische, A., Harboe, Z. B., Nielsen, A. C. Y., Fomsgaard, A., Krogfelt, K. A., & Jørgensen, C. S. (2020) · medRxiv · doi:10.1101/2020.04.09.20056325 · Cited by 319

MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015

Choe, P. G., Perera, R. A. P. M., Park, W. B., Song, K.-H., Bang, J. H., Kim, E. S., Kim, H. B., Ko, L. W. R., Park, S. W., Kim, N.-J., et al. (2017) · Emerging Infectious Diseases · doi:10.3201/eid2307.170310 · Cited by 227

Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward

Bryant, J. E., Azman, A. S., Ferrari, M. J., Arnold, B. F., Boni, M. F., Boum, Y., Hayford, K. T., Luquero, F. J., Mina, M. J., Rodríguez-Barraquer, I., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abc6347 · Cited by 142

Herd immunity is not a realistic exit strategy during a COVID-19 outbreakPreprint

Slot, E., Hogema, B. M., Reusken, C. B. E. M., Reimerink, J. H. J., Molier, M., Karregat, J. H. M., IJlst, J., Novotny, V. M. J., van Lier, R. A. W., & Zaaijer, H. L. (2020) · Research Square · doi:10.21203/rs.3.rs-25862/v1 · Cited by 55

SARS-CoV-2 infection among asymptomatic homebound subjects in Milan, Italy

Milani, G. P., Montomoli, E., Bollati, V., Albetti, B., Bandi, C., Bellini, T., Bonzini, M., Buscaglia, M., Cantarella, C., Cantone, L., et al. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.06.010 · Cited by 13

A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 Infection and Its Application in a Population-Based Survey by Mail

Egorov, A. I., Griffin, S. M., Fuzawa, M., Kobylanski, J., Grindstaff, R. D., Padgett, W. T., Simmons, S. O., Hallinger, D. R., Styles, J. N., Wickersham, L. C., et al. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00693-21 · Cited by 13

Recent findings and applications of biomedical engineering for COVID-19 diagnosis: a critical review

Bui, L. M., Phùng, H. T. T., Thi, T.-T. H., Singh, V., Maurya, R., Khambhati, K., Wu, C., Uddin, M. J., Trung, D. M., & Chu, D. (2021) · Bioengineered · doi:10.1080/21655979.2021.1987821 · Cited by 16

Performance of the COVID19SEROSpeed IgM/IgG Rapid Test, an Immunochromatographic Assay for the Diagnosis of SARS-CoV-2 Infection: a Multicenter European Study

Plebani, M., Parčina, M., Bechri, I., Zehender, G., Terkeš, V., Hafith, B. A., Antinori, S., Pillet, S., Gonzalo, S., Hoerauf, A. M., et al. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.02240-20 · Cited by 13

Suitability of two rapid lateral flow immunochromatographic assays for predicting SARS‐CoV‐2 neutralizing activity of sera

Valdivia, A., Torres, I., Latorre, V., Francés‐Gómez, C., Ferrer, J., Forqué, L., Costa, R. E. P. D., de la Asunción, C. S., Huntley, D., Gozalbo‐Rovira, R., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26697 · Cited by 13

Significance of IgA antibody testing for early detection of SARS‐CoV‐2

Wang, P. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26703 · Cited by 13

Lack of Antibodies to SARS-CoV-2 among Blood Donors during COVID-19 Lockdown: A Study from Saudi Arabia

Alandijany, T. A., El-Kafrawy, S. A., Alghamdi, A., Qashqari, F. S., Faizo, A. A., Tolah, A. M., Hassan, A. M., Sohrab, S. S., Hindawi, S., Badawi, M. A., et al. (2021) · Healthcare · doi:10.3390/healthcare9010051 · Cited by 12

SERS-based assay for multiplexed detection of cross-reactivity and persistence of antibodies against the spike of the native, P.1 and B.1.617.2 SARS-CoV-2 in non-hospitalised adults

Chisanga, M., Stuible, M., Gervais, C., L’Abbé, D., Cass, B., Bisson, L., Pelletier, A., Lord‐Dufour, S., Durocher, Y., Boudreau, D., et al. (2022) · Sensors & Diagnostics · doi:10.1039/d2sd00073c · Cited by 16

Rapid Serological Tests for SARS-CoV-2: Diagnostic Performance of 4 Commercial Assays

de Almeida, S. M., Spalanzani, R. N., Nogueira, M. B., Sanada, B., Cavalli, B. M., Rotta, I., Takahashi, G. R. A., Pereira, L. A., Moreira, F. B., Dino, C. L. T., et al. (2021) · Medical Principles and Practice · doi:10.1159/000516776 · Cited by 12

Diagnostic Performance of Seven Commercial COVID-19 Serology Tests Available in South America

Rivera-Olivero, I. A., Henriquez-Trujillo, A. R., Kyriakidis, N. C., Ortiz‐Prado, E., Laglaguano, J. C., Vallejo-Janeta, A. P., Lozada, T., García-Bereguiain, M. Á., & UDLA COVID-19 team (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.787987 · Cited by 12

Performance characteristics of five SARS-CoV-2 serological assays: Clinical utility in health-care workers

Heffernan, E., Kennedy, L., Hannan, M. M., Ramlaul, N., Denieffe, S., Courtney, G., Watt, A. P., Hurley, J. P., Lynch, M. R., & Fitzgibbon, M. C. (2021) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/00045632211012728 · Cited by 12

The Study to Investigate COVID-19 Infection in People Living in Ireland (SCOPI): A seroprevalence study, June to July 2020

Heavey, L., Garvey, P., Colgan, A. M., Thornton, L., Connell, J., Roux, T., Hunt, M., O'Callaghan, F., Culkin, F., Keogan, M., et al. (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.48.2001741 · Cited by 10

Evaluating SARS-CoV-2 Seroconversion Following Relieve of Confinement Measures

Gonçalves, J., Sousa, R., Jacinto, M. J., Amaral-Silva, D., Paula, F. S., de Sousa, R. D., Zahedi, S., Carvalho, J. A., Cabral, M. G., Costa, M., et al. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.603996 · Cited by 9

Seroprevalence of neutralizing antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among healthcare workers in Makkah, Saudi Arabia

Ahmed, W., Dada, A. M., Alshukairi, A. N., Sohrab, S. S., Faizo, A. A., Tolah, A. M., El-Kafrawy, S. A., Bajrai, L. H., Moalim, H. M., Aly, M. H., et al. (2021) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2021.101366 · Cited by 11

The dynamics of quantitative SARS‐CoV‐2 antispike IgG response to BNT162b2 vaccination

Kaneko, S., Kurosaki, M., Sugiyama, T., Takahashi, Y., Yamaguchi, Y., Nagasawa, M., & Izumi, N. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27231 · Cited by 10

Multiplex assessment of SARS-CoV-2 antibodies improves assay sensitivity and correlation with neutralizing antibodies

Cook, N., Xu, L., Hegazy, S. E., Wheeler, B. J., Anderson, A., Critelli, N., Yost, M., McElroy, A. K., Shurin, M. R., & Wheeler, S. (2021) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2021.08.006 · Cited by 11

The Trend of IgG and IgM Antibodies During 6-Month Period After the Disease Episode in COVID-19 Patients

Ghasemi, D., Araeynejad, F., Maghsoud, O., Gerami, N., Keihan, A. H., Rezaie, E., Mehdizadeh, S., Hosseinzadeh, R., Mohammadi, R., Bahardoust, M., et al. (2022) · Iranian Journal of Science and Technology Transactions A Science · doi:10.1007/s40995-022-01382-7 · Cited by 11

Sensitivity and specificity of 14 SARS-CoV-2 serological assays and their diagnostic potential in RT-PCR negative COVID-19 infections

Honacker, E. V., Coorevits, L., Boelens, J., Verhasselt, B., Braeckel, E. V., Bauters, F. A., Bus, L. D., Schelstraete, P., Willems, J., Vandendriessche, S., et al. (2020) · Acta Clinica Belgica · doi:10.1080/17843286.2020.1861885 · Cited by 11

Disparities of SARS-CoV-2 Nucleoprotein-Specific IgG in Healthcare Workers in East London, UK

Choudhry, N., Drysdale, K., Usai, C., Leighton, D., Sonagara, V. J., Buchanan, R., Nijjar, M., Thomas, S., Hopkins, M. J., Cutiño‐Moguel, T., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.642723 · Cited by 11

High-throughput immunoassays for SARS-CoV-2 – considerable differences in performance when comparing three methods

Ekelund, O., Ekblom, K., Somajo, S., Pattison-Granberg, J., Olsson, K., & Petersson, A. (2021) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2021.1931434 · Cited by 11

Diagnostic TR-FRET assays for detection of antibodies in patient samples

Yue, H., Nowak, R. P., Overwijn, D., Payne, N. C., Fischinger, S., Atyeo, C. G., Lam, E. C., Denis, K. S., Brais, L. K., Konishi, Y., et al. (2023) · Cell Reports Methods · doi:10.1016/j.crmeth.2023.100421 · Cited by 11

Analysis of Recent Bio-/Nanotechnologies for Coronavirus Diagnosis and Therapy

Rhouati, A., Teniou, A., Badea, M., & Marty, J. (2021) · Sensors · doi:10.3390/s21041485 · Cited by 11

Screening the General Population for SARS-CoV-2 Virus and COVID-19 Antibodies: A Counterargument

Wu, A. H. B. (2020) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfaa104 · Cited by 10

Comparison of virus neutralization activity and results of 10 different anti-SARS-CoV-2 serological tests in COVID-19 recovered plasma donors

Szabó, Z., Szabó, T. G., Bodó, K., Kemenesi, G., Földes, F., Kristóf, K., Barabás, E., Vásárhelyi, B., Prohászka, Z., Fodor, E. K., et al. (2021) · Practical Laboratory Medicine · doi:10.1016/j.plabm.2021.e00222 · Cited by 10

Heterologous Immune Responses of Serum IgG and Secretory IgA Against the Spike Protein of Endemic Coronaviruses During Severe COVID-19

Smit, W. L., van Tol, S., van der Wal, S., van Vulpen, F., la Grouw, S., van Lelyveld, L., Limonard, G. J. M., Bossink, A. W. J., Godeke, G.-J., Shrestha, S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.839367 · Cited by 10

Review on In Silico Methods, High-throughput Screening Techniques, and Cell Culture Based In Vitro Assays for SARS-CoV-2

Çetin, Y., Aydınlık, Ş., Güngör, A., Kan, T., Avşar, T., & Durdağı, S. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220627121416 · Cited by 11

Evaluation of a new simultaneous anti-SARS-CoV-2 IgA, IgM and IgG screening automated assay based on native inactivated virus

Nuccetelli, M., Pieri, M., Gisone, F., Sarubbi, S., Ciotti, M., Andreoni, M., & Bernardini, S. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107330 · Cited by 10

Qualitative and quantitative detection of SARS-CoV-2 antibodies from dried blood spots

Omosule, C. L., Conklin, J., Seck, S., Howell, R., Hock, K. G., Ballman, C., Freeman, J., du Toit, L., Dubberke, E. R., & Farnsworth, C. W. (2022) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2021.12.012 · Cited by 10

Multiplex metal-detection based assay (MMDA) for COVID-19 diagnosis and identification of disease severity biomarkers

Zhou, Y., Yuan, S., To, K. K., Xu, X., Li, H., Cai, J., Luo, C., Hung, I. F., Chan, K., Yuen, K., et al. (2022) · Chemical Science · doi:10.1039/d1sc05852e · Cited by 10

The study to investigate COVID-19 infection in people living in Ireland (SCOPI): a seroprevalence study, June to July 2020

Heavey, L., Garvey, P., Colgan, A., Thornton, L., Connell, J., (1444018), T. R., Hunt, M., O'Callaghan, F., Culkin, F., Keogan, M. T., et al. (2022) · Figshare · Cited by 10

COVID-19 infection among emergency department healthcare providers in a large tertiary academic medical center following the peak of the pandemic

Murakami, E., Ghatak‐Roy, A., Popova, M., Gannon, C., Park, D. E., Villani, J., Liu, C. H., Toma, I., & Lafleur, J. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.11.064 · Cited by 9

Performance of five rapid serological tests in mild-diseased subjects using finger prick blood for exposure assessment to SARS-CoV-2

Triest, D., Geebelen, L., Pauw, R. D., Craeye, S. D., Vodolazkaia, A., Verbrugghe, M., Magerman, K., Robben, L.-L., Pannus, P., Neven, K. Y., et al. (2021) · Journal of Clinical Virology · doi:10.1016/j.jcv.2021.104897 · Cited by 9

Comparison of Anti–SARS-CoV-2 S1 Receptor-Binding Domain Antibody Immunoassays in Health Care Workers Before and After the BNT162b2 mRNA Vaccine

Carta, M., Marinello, I., Cappelletti, A., Rodolfi, A., Cerrito, E., Bernasconi, C., Gottardo, M., Lago, F. D., Rizzetto, D., Barzon, E., et al. (2021) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqab107 · Cited by 10

Use of convalescent plasma for COVID-19 in India

Khaire, N. S., Jindal, N., Yaddanapudi, L. N., Sachdev, S., Hans, R., Sachdeva, N. K., Singh, M. P., Agarwal, A., Mukherjee, A., Kumar, G., et al. (2021) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_3092_20 · Cited by 9

SARS-CoV-2, Zika viruses and mycoplasma: Structure, pathogenesis and some treatment options in these emerging viral and bacterial infectious diseases

Ferreira, G., Santander, A., Savio, F., Guirado, M., Sobrevía, L., & Nicolson, G. L. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166264 · Cited by 10

The prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff - study protocol description and presentation of preliminary findings on symptoms.

Goossens, M. E., Neven, K. Y., Pannus, P., Barbezange, C., Thomas, I., Gucht, S. V., Dierick, K., Schmickler, M.-N., Verbrugghe, M., Loon, N. V., et al. (2021) · Archives of Public Health · doi:10.1186/s13690-021-00715-z · Cited by 9

Differences in systemic and mucosal SARS-CoV-2 antibody prevalence in a prospective cohort of Dutch children

Keuning, M. W., Grobben, M., Bijlsma, M. W., Anker, B., Jong, E. P. B.-D., Cohen, S., Felderhof, M. K., de Groen, A.-E. C., de Groof, F., Rijpert, M., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.976382 · Cited by 9

Performance of 4 Automated SARS-CoV-2 Serology Assay Platforms in a Large Cohort Including Susceptible COVID-19–Negative and COVID-19–Positive Patients

Ward, M. D., Mullins, K., Pickett, E., Merrill, V. D., Ruiz, M., Rebuck, H., Duh, S., & Christenson, R. H. (2021) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfab014 · Cited by 8

Review of Clinical Performance of Serology Based Commercial Diagnostic Assays for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies

Deshpande, P. S., Abraham, I. E., Pitamberwale, A., & Dhote, R. H. (2022) · Viral Immunology · doi:10.1089/vim.2020.0313 · Cited by 8

Implementation and Extended Evaluation of the Euroimmun Anti-SARS-CoV-2 IgG Assay and Its Contribution to the United Kingdom’s COVID-19 Public Health Response

Otter, A. D., Bown, A., D’Arcangelo, S., Bailey, D., Semper, A. E., Hewson, J., Catton, M., Perumal, P., Sweed, A., McKee, D. F., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02289-21 · Cited by 7

COVID-19 vaccine effectiveness among healthcare workers in Albania (COVE-AL): protocol for a prospective cohort study and cohort baseline data

Sridhar, S., Fico, A., Preza, I., Hatibi, I., Sulo, J., Kissling, E., Daja, R., Ibrahim, R., Lemos, D. S., Rubin-Smith, J. E., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-057741 · Cited by 8

Serosurvey for SARS-CoV-2 among blood donors in Wuhan, China from September to December 2019

Chang, L., Zhao, L., Xiao, Y., Xu, T., Chen, L., Cai, Y., Dong, X., Wang, C., Xiao, X., Ren, L., et al. (2022) · Protein & Cell · doi:10.1093/procel/pwac013 · Cited by 11

Antibody responses in COVID-19 patients

Liu, S., & Lu, S. (2020) · Journal of Biomedical Research · doi:10.7555/jbr.34.20200134 · Cited by 8

Severe acute respiratory syndrome coronavirus 2 antibody seroprevalence in Lebanon: a population-based cross-sectional study

Mahdi, A., Khazen, G., Aziz, N., Mina, J., Papazian, A., Daou, L., Ahmar, J., Assaf, N., Abdulkhalek, A., Farhat, H. Z., et al. (2022) · IJID Regions · doi:10.1016/j.ijregi.2022.01.011 · Cited by 7

Evaluation of Humoral Immunity to SARS-CoV-2: Diagnostic Value of a New Multiplex Addressable Laser Bead Immunoassay

Drouot, L., Hantz, S., Jouen, F., Velay, A., Lamia, B., Veber, B., Sibilia, J., Lotellier, M., Candon, S., Alain, S., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.603931 · Cited by 7

Integrated System for On-Site Rapid and Safe Screening of COVID-19

Zhang, D., Guo, Y., Zhang, L., Wang, Y., Peng, S., Duan, S., Geng, L., Zhang, X., Wang, W. J., Yang, M., et al. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c02337 · Cited by 7

Prevalence and Course of IgA and IgG Antibodies against SARS-CoV-2 in Healthcare Workers during the First Wave of the COVID-19 Outbreak in Germany: Interim Results from an Ongoing Observational Cohort Study

Reinwald, M., Deckert, P. M., Ritter, O., Andresen, H., Schreyer, A. G., Weylandt, K. H., Dammermann, W., & Lüth, S. (2021) · Healthcare · doi:10.3390/healthcare9050498 · Cited by 7

Bacterial ligands as flexible and sensitive detectors in rapid tests for antibodies to SARS-CoV-2

Cavalera, S., Nardo, F. D., Chiarello, M., Serra, T., Colitti, B., Guiotto, C., Fagioli, F., Cagnazzo, C., Denina, M., Palazzo, A., et al. (2022) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-022-03939-2 · Cited by 7

A multiplexed high-throughput neutralization assay reveals a lack of activity against multiple variants after SARS-CoV-2 infectionPreprint

Fenwick, C. W., Turelli, P., Pellaton, C., Farina, A., Campos, J., Raclot, C., Pojer, F., Cagno, V., Pantaleo, G., & Trono, D. (2021) · medRxiv · doi:10.1101/2021.04.08.21255150 · Cited by 7

Differential abundance of IgG antibodies against the spike protein of SARS-CoV-2 and seasonal coronaviruses in patients with fatal COVID-19

Smit, W. L., van Tol, S., Haas, L. E. M., Limonard, G. J. M., Bossink, A. W. J., Reusken, C. B. E. M., Heron, M., & Thijsen, S. F. T. (2023) · Virology Journal · doi:10.1186/s12985-023-02050-x · Cited by 6

Comparative Longitudinal Serological Study of Anti-SARS-CoV-2 Antibody Profiles in People with COVID-19

Barrios, M. H., Nicholson, S. R., Bull, R. A., Martinello, M., Rawlinson, W. D., Mina, M., Post, J. J., Hudson, B. J., Gilroy, N. M., Lloyd, A. R., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11081985 · Cited by 4

Case Report: Adequate T and B Cell Responses in a SARS-CoV-2 Infected Patient After Immune Checkpoint Inhibition

de Joode, K., Oostvogels, A. A. M., GeurtsvanKessel, C. H., de Vries, R. D., Mathijssen, R. H. J., Debets, R., & van der Veldt, A. A. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.627186 · Cited by 7

Sero-Prevalence and Sero-Incidence of Antibodies to SARS-CoV-2 in Health Care Workers in Israel, Prior to Mass COVID-19 Vaccination

Muhsen, K., Schwaber, M. J., Bishara, J., Kassem, E., Atamna, A., Na’amnih, W., Goren, S., Bialik, A., Mohsen, J., Zaaide, Y., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.689994 · Cited by 6

Correlation between Commercial Anti-RBD IgG Titer and Neutralization Titer against SARS-CoV-2 Beta Variant

Poon, R. W., Lu, L., Fong, C. H.-Y., Ip, T.-C., Chen, L., Zhang, R., Yip, C. C., Cheng, V. C., Chan, K., Yuen, K., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11122216 · Cited by 5

Design and optimization of an IgG human ELISA assay reactive to recombinant RBD SARS-CoV-2 protein

Rodríguez, M. C., Ceaglio, N., Gugliotta, A., Villarraza, J., Garay, E., Fuselli, A., Gastaldi, V., Tardivo, M. B., Antuña, S., Fontana, D., et al. (2022) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-022-12254-w · Cited by 5

Population-based sero-epidemiological investigation of SARS-CoV-2 infection in Somalia

Hossain, M. S., Derow, M., Mohamed, S. I., Abukar, H. M., Qayad, M. G., Malik, S. M. M. R., Mengistu, K. F., Obsie, A. A. A., & Anwar, I. (2023) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2023.04.016 · Cited by 4

Estimating SARS-CoV-2 infection probabilities with serological data and a Bayesian mixture model

Glémain, B., de Lamballerie, X. N., Zins, M., Severi, G., Touvier, M., Deleuze, J., SAPRIS-SERO study group, Carrat, F., Ancel, P., Charles, M.-A. A., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-60060-3 · Cited by 5

Mortality Reduction in ICU-Admitted COVID-19 Patients in Suriname after Treatment with Convalescent Plasma Acquired Via Gravity Filtration

Bihariesingh-Sanchit, R., Bihariesingh-Sanchit, R., Bansie, R., Fröberg, J., Ramdhani, N., Mangroo, R., Bustamente, D., Diaz, E., Thakoer, I., Vreden, S., et al. (2021) · Anesthesia and Clinical Research · doi:10.31487/j.acr.2021.02.03 · Cited by 5

Evaluation of different platforms for the detection of anti-SARS coronavirus-2 antibodies, Thailand

Lerdsamran, H., Mungaomklang, A., Iamsirithaworn, S., Prasertsopon, J., Prasert, K., Intalapaporn, P., Siriyakorn, N., Wiriyarat, W., Thinpan, N., Sawadpongpan, S., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06921-y · Cited by 6

Probabilistic classification of anti‐SARS‐CoV‐2 antibody responses improves seroprevalence estimates

Dopico, X. C., Muschiol, S., Grinberg, N. F., Aleman, S., Sheward, D. J., Hanke, L., Ahl, M., Vikström, L., Forsell, M. N. E., Coquet, J. M., et al. (2022) · Clinical & Translational Immunology · doi:10.1002/cti2.1379 · Cited by 4

SARS-CoV-2 Seroprevalence in a Cohort of Asymptomatic RT-PCR Negative Croatian First League Football Players

Vince, A., Zadro, R., Šostar, Z., Sternak, S. L., Vraneš, J., Škaro, V., Projić, P., Molnar, V., Matišić, V., Baršić, B., et al. (2021) · Journal of Pharmacy and Pharmacology Research · doi:10.26502/fjppr.046 · Cited by 4

Differential vaccine-induced kinetics of humoral and cellular immune responses in SARS-CoV-2 naive and convalescent health care workers

Smit, W. L., Thijsen, S. F. T., van der Kieft, R., van Tol, S., Reimerink, J. H. J., Reusken, C. B. E. M., Rümke, L. W., Bossink, A. W. J., Limonard, G. J. M., & Heron, M. (2022) · Pathogens and Disease · doi:10.1093/femspd/ftac035 · Cited by 5

INSIGHT OF PANDEMIC COVID-19: DEVELOPMENTS AND CHALLENGES

Muneer, M. A., Arshad, M., Abbas, G., Arshad, M., Munir, K., Iqbal, A., Mustafa, A., Amin, Q., Khan, M. A., Qureshi, R. A., et al. (2023) · Pakistan Journal of Science · doi:10.57041/pjs.v75i1.831 · Cited by 4

The seroprevalence of SARS‐CoV‐2 infection in Malaysia: 7 August to 11 October 2020

Chong, Z. L., Hasani, W. S. R., Asari, F. N., Muhammad, E. N., Mutalip, M. H. A., Lourdes, T. G. R., Rifin, H. M., Singh, S., & Thayan, R. (2023) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.13193 · Cited by 4

Multicentric evaluation of sensitivity of eight commercial anti-SARS-CoV-2 antibody assays and their correlation to virus neutralization titers in seropositive subjects

Fajfr, M., Pajer, P., Růžek, D., Sleha, R., Janovská, S., Bohoněk, M., Kabíčková, H., Kubíčková, P., Štefánik, M., Straková, P., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-51968-x · Cited by 4

Quantification of SARS-CoV-2 monoclonal IgG mass fraction by isotope dilution mass spectrometry

Martos, G., Bedu, M., Josephs, R. D., Westwood, S. W., & Wielgosz, R. I. (2024) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-024-05205-z · Cited by 4

SARS-CoV-2 tests in occupational settings: what you look for is what you get

Ferrari, L., Nigro, S., Bordini, L., Carugno, M., & Bollati, V. (2021) · La Medicina del Lavoro · doi:10.23749/mdl.v112i3.11472 · Cited by 4

Rapid antibody diagnostics for SARS-CoV-2 adaptive immune response

Afzal, A., Iqbal, N., Feroz, S., Ali, A., Ehsan, M. A., Khan, S. A., & Rehman, A. (2021) · Analytical Methods · doi:10.1039/d1ay00888a · Cited by 3

Development of Serological Assays and Seroprevalence Studies of the New Coronavirus 2019 (COVID-19): Reports from Saudi Arabia

Alandijany, T. A., & Faizo, A. A. (2021) · Healthcare · doi:10.3390/healthcare9121730 · Cited by 4

Applying mixture model methods to SARS-CoV-2 serosurvey data from Geneva

Bouman, J. A., Kadelka, S., Stringhini, S., Pennacchio, F., Meyer, B., Yerly, S., Kaiser, L., Guessous, I., Azman, A. S., Bonhoeffer, S., et al. (2022) · Epidemics · doi:10.1016/j.epidem.2022.100572 · Cited by 4

Evaluation of Convalescent Plasma in the Management of Critically Ill COVID-19 Patients (with No Detectable Neutralizing Antibodies Nab) in Kashmir, India

Elkhalifa, A., Nabi, S. U., Shah, N., Dar, K., Quibtiya, S., Bashir, S., Ali, S. I., Taifa, S., & Hussain, I. (2023) · Healthcare · doi:10.3390/healthcare11030317 · Cited by 4

Heterologous vaccination (ChAdOx1 and BNT162b2) induces a better immune response against the omicron variant than homologous vaccination

Yoo, J., Kim, Y. J., Mi, Y., Lee, J., Jeong, Y. J., Kim, S., Maragakis, L. L., & Lee, S. (2023) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2023.07.017 · Cited by 4

Point of care detection of SARS-CoV-2 antibodies and neutralisation capacity—lateral flow immunoassay evaluation compared to commercial assay to inform potential role in therapeutic and surveillance practices

McGrath, J., O’Doherty, L., Conlon, N. P., Dunne, J., Brady, G., Ibrahim, A., McCormack, W. J., Walsh, C., Domegan, L. M., Walsh, S., et al. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1245464 · Cited by 4

Sewage surveillance system using urological wastewater: Key to COVID-19 monitoring?

de Jong, F. C., GeurtsvanKessel, C. H., Molenkamp, R., Bangma, C. H., & Zuiverloon, T. C. M. (2020) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2020.10.008 · Cited by 4

SARS-CoV-2 IgG Antibody and its Clinical Correlates in Convalescent Plasma Donors: An Indian Experience

Kumar, P. K., Banerjee, M., Bajpayee, A., Mandal, S., Mitra, P., Sharma, P., Misra, S., & Bhardwaj, P. (2021) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-021-01012-w · Cited by 4

Serological testing for SARS-CoV-2 antibodies in clinical practice: a comparative diagnostic accuracy studyPreprint

Horn, M. P., Jónsdóttir, H. R., Brigger, D., Damonti, L., Suter‐Riniker, F., Endrich, O., Fröhlich, T., Fiedler, M., Largiadèr, C. R., Marshall, J., et al. (2021) · doi:10.22541/au.162802497.73057952/v1 · Cited by 4

Evaluation of SARS-CoV-2 Seroprevalence and Variant Distribution During the Delta–Omicron Transmission Waves in Greater Accra, Ghana, 2021

Lomotey, E. S., Akorli, J., Opoku, M., Odumang, D. A., Nketia, K., Gyekye, E. F., Sedzro, K. M., Andoh, N. E., Ashong, Y. A., Abuaku, B. K., et al. (2025) · Viruses · doi:10.3390/v17040487 · Cited by 3

Comparative assessment of homemade ELISA and lateral flow assay (LFA)in the rapid, specific and sensitive detection of SARS-CoV-2 anti-nucleocapsid protein in sera of Egyptian patients

El‐Shershaby, A., Hussein, N. A., Ali, E., El-Hakim, A. E., Tabll, A. A., Shaheen, M. N. F., Ali, I., Elshall, M., & Shahein, Y. E. (2023) · Journal of Immunoassay and Immunochemistry · doi:10.1080/15321819.2023.2224865 · Cited by 3

Applications of nanostructured materials for severe acute respiratory syndrome-CoV-2 diagnostic

Turab, N. M., Owida, H. A., Al-Nabulsi, J., & Alnaimat, F. (2024) · Bulletin of Electrical Engineering and Informatics · doi:10.11591/eei.v13i4.7325 · Cited by 3

Comparative evaluation of in-house ELISA and two commercial serological assays for the detection of antibodies against SARS-CoV-2

Gobena, D., Gudina, E. K., Degfie, T. T., Girma, T., Gebre, G., Abdissa, A., Tafesse, F., Gelanew, T. I., & Mekonnen, Z. (2025) · Scientific Reports · doi:10.1038/s41598-025-97050-y · Cited by 3

SARS-CoV-2 Seroepidemiological Investigation in Jordan: Seroprevalence, Herd Immunity, and Vaccination Coverage. A Population-Based National Study

Ali, S. S., Kheirallah, K. A., Sharkas, G. F., Al-Nusair, M., Al-Mistarehi, A.-H. W., Ghazo, M., Zeitawi, A., Bellizzi, S., Ramadan, M., Alsulaiman, J., et al. (2022) · International Journal of General Medicine · doi:10.2147/ijgm.s371711 · Cited by 3

Correlation of SARS-CoV-2 Neutralization with Antibody Levels in Vaccinated Individuals

Chowdhury, S. H., Riley, S., Mikolajczyk, R., Smith, L. N., Suresh, L., & Jacobs, A. (2023) · Viruses · doi:10.3390/v15030793 · Cited by 3

Clinical validation of novel dried blood spot based collecting device using serum separation for measuring SARS‐CoV‐2 antibodies

Stekhoven, S. S., Winkel, K. G. T., Souverein, D., Sondermeijer, B. M., van Houten, M. A., Euser, S. M., & van Lelyveld, S. F. L. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28765 · Cited by 3

Serosurveillance among COVID-19 Cases in Ahmedabad Using SARS-COV2 IgG Antibodies

Prakash, O., Solanki, B., Sheth, J. K., Maitrak, D., Kadam, M., Vyas, S., Shukla, A. A., & Tiwari, H. (2021) · Indian Journal of Community Health · doi:10.47203/ijch.2021.v33i02.022 · Cited by 3

Seroprevalence of SARS-CoV-2 Neutralizing Antibodies among Blood Donors in Ho Chi Minh City, Vietnam, August–November 2020

Nguyen, H. H. H., Nguyen, Q. H., Truong, D. T. T., Manh, D. H., Le, T. N., Nguyen, H. T., Nguyen, A. H., Nguyen, T. V., Hoang, D. T. N., Hoang, L. K., et al. (2022) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.21-0259 · Cited by 3

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulins using chemiluminescence immunoassay and its correlation with neutralizing antibodies

Gaber, Y., Alem, S. A., Musa, S., Amer, K., Elnagdy, T., Hassan, W. A., Abdel-Rahman, R. Z., Gad, A. F., Ali, M. A., Badary, H. A., et al. (2022) · Virus Research · doi:10.1016/j.virusres.2022.198852 · Cited by 3

Evaluation of the Anti-Spike (RDB) IgG Titer among Workers Employed at the University of Pisa Vaccinated with Different Types of SARS-CoV-2 Vaccines

Foddis, R., Marino, R., Silvestri, R., Fallahi, P., Perretta, S., Garaffa, C., Morganti, R., Corsi, M., Mennucci, J., Porciatti, F., et al. (2022) · Vaccines · doi:10.3390/vaccines10081244 · Cited by 3

Re-evaluating positive serum samples for SARS-CoV-2-specific IgA and IgG antibodies using an in-house serological assay

Cacaci, M., Menchinelli, G., Ricci, R., Maio, F. D., Mariotti, M., Torelli, R., Morandotti, G. A., Bugli, F., Sanguinetti, M., & Posteraro, B. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.12.014 · Cited by 2

Antibody indexes in COVID-19 convalescent plasma donors: Unanswered questions

Bonetti, T. C., Latini, F. R. M., Invitti, A. L., Fonseca, M. C. M., Scorza, F. A., Saldanha, M. G., Bellucco, F. T. D. S., Bacarov, N. B., Soane, M. M., & Girão, M. J. B. C. (2021) · Clinics · doi:10.6061/clinics/2021/e2818 · Cited by 3

SARS-CoV-2 seroprevalence in blood donors before and after the first wave in Catalonia (Spain).

Pirón, M., Jané, M., Ciruela, P., Basile, L., Martı́nez, A., Puig, L., Bes, M., & Sauleda, S. (2022) · PubMed Central · doi:10.2450/2022.0232-21 · Cited by 3

Outlining the Prior Infection with SARS-CoV-2 study (PICOV) - preliminary findings on symptoms in nursing home residents and staff.Preprint

Goossens, M. E., Neven, K. Y., Pannus, P., Barbezange, C., Thomas, I., Gucht, S. V., Dierick, K., Schmickler, M.-N., Verbrugghe, M., Loon, N. V., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-310079/v1 · Cited by 3

Label-Free Plasmonic Biosensor for Rapid, Quantitative, and Highly Sensitive COVID-19 Serology: Implementation and Clinical ValidationPreprint

Calvo-Lozano, O., Sierra, M., Soler, M., Estévez, M. ‐., Chiscano‐Camón, L., Ruiz-Sanmartín, A., Ruiz‐Rodríguez, J. C., Ferrer, R., González‐López, J. J., Esperalba, J., et al. (2021) · ChemRxiv · doi:10.26434/chemrxiv.14595654.v1 · Cited by 3

Interferon-α Auto-Antibodies in Convalescent Plasma Therapy for COVID-19Preprint

Raadsen, M. P., Gharbharan, A., Jordans, C. C. E., Mykytyn, A. Z., Lamers, M. M., van den Doel, P. B., Endeman, H., van den Akker, J. P. C., GeurtsvanKessel, C. H., Koopmans, M., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-670949/v1 · Cited by 3

Numerical Design of a High-Sensitivity SPR Biosensor for Spike and Nucleoprotein RBD Detection in SARS-CoV-2 Diagnostics

Ayyanar, N., Kamaleshwar, M., Ramanujam, N. R., Raja, G. T., Skibina, J. S., & Al-Zahrani, F. A. (2025) · IEEE Transactions on Plasma Science · doi:10.1109/tps.2025.3559679 · Cited by 2

Importance of anti-SARS-CoV-2 assay antigenic composition as revealed by the results of the Belgian external quality assessment (EQA) scheme

Moerman, A., Vernelen, K., China, B., Capron, A., den Bossche, D. V., Mariën, J., Ariën, K. K., Acker, J. V., Delforge, M., Reynders, M., et al. (2021) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2021.115561 · Cited by 2

Severe Acute Respiratory Syndrome Coronavirus 2 Antigens as Targets of Antibody Responses

Ogata, A. F., Lazarovits, R., Uwamanzu‐Nna, A., Gilboa, T., Cheng, C., & Walt, D. R. (2021) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2021.10.002 · Cited by 2

Clinical utility of indirect fluorescent assay for IgA class antibodies against Bartonella henselae in serodiagnosis of cat scratch disease in its early stage

Tsuneoka, H., Otsuyama, K., Hirano, A., Nojima, J., Nishikawa, J., & Ichihara, K. (2022) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2022.115809 · Cited by 2

Seroprevalence of IgG and IgM Antibodies against SARS-CoV-2 Infection in Inhabitants of Itanagar Capital Region, Arunachal Pradesh, India

Mona, A. K. A. D., SOCOLOV, R., COVALI, R., Catalina Daniela, S. T. A. N., CRAUCIUC, E., POPOVICI, D., Cristinel Ionel, S. T. A. N., Fawzy, A. K. A. D., & SOCOLOV, D. (2023) · MAEDICA – a Journal of Clinical Medicine · doi:10.26574/maedica.2023.18.1.88 · Cited by 2

Seroprevalence of SARS-CoV-2 antibodies among healthcare workers in Dutch hospitals after the 2020 first wave: a multicentre cross-sectional study with prospective follow-up

Recanatini, C., GeurtsvanKessel, C. H., Pas, S. D., Broens, E. M., Maas, M. L., van Mansfeld, R., Oudheusden, A. M.-V., van Rijen, M., Schippers, E. F., Stegeman, A., et al. (2023) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-023-01324-x · Cited by 2

Longitudinal analysis of SARS-CoV-2 IgG antibody durability in Puerto Rico

Madewell, Z. J., Graff, N., Lopez, V. K., Rodríguez, D. M., Wong, J. M., Maniatis, P., Medina, F. A., Muñoz, J. L., Briggs‐Hagen, M., Adams, L. E., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-80465-4 · Cited by 2

Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance

Nicholson, S. R., Karapanagiotidis, T., Khvorov, A., Douros, C., Mordant, F. L., Bond, K. A., Druce, J. D., Williamson, D. A., Purcell, D. F. J., Lewin, S. R., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab239 · Cited by 28

Evaluation of High-Throughput SARS-CoV-2 Serological Assays in a Longitudinal Cohort of Patients with Mild COVID-19: Clinical Sensitivity, Specificity, and Association with Virus Neutralization Test

Bal, A., Pozzetto, B., Trabaud, M., Escuret, V., Rabilloud, M., Langlois, C., Paul, A., Guibert, N., d’Aubarede, C., Massardier-Pilonchery, A., et al. (2021) · Clinical Chemistry · doi:10.1093/clinchem/hvaa336 · Cited by 74

Measuring Humoral Immune Responses to SARS-CoV-2: A Comprehensive Review of Serological Assays

Xue, H., Haynesworth, K., Hempel, H., Kemp, T. J., & Pinto, L. A. (2026) · Vaccines · doi:10.3390/vaccines14050395

Comparison of different serological assays for SARS-CoV-2 in real life

Brochot, É., Demey, B., Handala, L., François, C., Duverlie, G., & Castelain, S. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104569 · Cited by 43

A Comparison of the Performance of SARS-CoV-2 Antibody Assays in Healthcare Workers with COVID-19.

Kerr, C., Dunne, J., Hughes, G., Cox, F., Healy, M., Holmes, P., O'Rourke, F., O'Brien, C., Coyne, D., Crowley, V., et al. (2021) · PubMed · Cited by 2